CANNAPHARMARX, INC. Deferred Income Tax Expense (Benefit)
CANNAPHARMARX, INC. (CPMD) reported Deferred Income Tax Expense (Benefit) of $3.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-03-31
- CANNAPHARMARX, INC. deferred income tax expense (benefit) for fiscal 2025 was $3.00M, a 75.98% increase from fiscal 2024.
- CANNAPHARMARX, INC. deferred income tax expense (benefit) for fiscal 2024 was $1.70M.
- CANNAPHARMARX, INC. deferred income tax expense (benefit) for fiscal 2023 was -$2.17M.
| Period end | Deferred Income Tax Expense (Benefit) 12 month |
|---|---|
| 2025-12-31 | $3.00M 10-K · filed 2026-03-31 |
| 2024-12-31 | $1.70M 10-K · filed 2026-03-31 |
| 2023-12-31 | -$2.17M 10-K · filed 2025-04-10 |